ELAN · NYSE · Pharmaceuticals
Pharmaceuticals company based in Greenfield, Indiana.
In the last 90 days, insiders of Elanco reported 5 open-market purchases worth about $1.47M and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$22.51
Last 12 months
Not enough history
Market value
$11.2B
Revenue
$1.37B
+10.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$379M
This quarter $244M, a year earlier $180M
Net debt
$3.13B
Debt $3.66B, cash $530M, at Jun 30, 2026
Net income, last 12 months
−$199M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 5, 2026.
Insiders buying, last 90 days
5 insiders
$1.47M bought in total
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$4.71B
+6.2% vs the year before
Net income, fiscal 2025
−$232M
A loss for the year
Shares outstanding
500M
As of Aug 3, 2026
Stock since the trade −4.5% · S&P 500 +1.6% · to Oct 5
A board member of Elanco paid $936K out of pocket for Elanco shares. 4 other people at Elanco bought some too, in the same month. It was the first purchase in 8 months.
Stock since the trade −4.8% · S&P 500 +1.0% · to Oct 5
Elanco's GC AND CORP SEC paid $94K out of pocket for Elanco shares. 4 other people at Elanco bought some too, in the same month.
Stock since the trade +1.7% · S&P 500 +0.3% · to Oct 5
A board member of Elanco paid $109K out of pocket for Elanco shares. 4 other people at Elanco bought some too, in the same month.
Stock since the trade +1.8% · S&P 500 +0.2% · to Oct 5
A board member of Elanco paid $237K out of pocket for Elanco shares. 4 other people at Elanco bought some too, in the same month. The Elanco shares held grew by 10%.
Stock since the trade +1.8% · S&P 500 +0.2% · to Oct 5
The money chief of Elanco paid $97K out of pocket for Elanco shares. 4 other people at Elanco bought some too, in the same month. It was the first purchase in 8 months.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $20.66 on Oct 6, 2025 to $22.51 on Oct 5, 2026 (+9.0%). Disclosed activity in the last 12 months: 10 insider purchases, 0 insider sales, 0 Congress purchases, 0 Congress sales. 3 groups of purchases by several insiders within a few days.
